memphis meats
Auto Added by WPeMatico
Auto Added by WPeMatico
On a recent morning in downtown Shenzhen, Lingyu queued up to order her go-to McMuffin. As she waited in line with other commuters, the 50-year-old accountant noticed the new vegetarian options on the menu and decided to try the imitation spam and scrambled egg burger.
“I’ve never had fake meat,” she said of the burger — one of five new breakfast items that McDonald’s introduced last week in three major Chinese cities featuring luncheon meat substitutes produced by Green Monday.
Although some investors worry the sudden boom of meat-substitute startups could turn into a bubble, others believe the market is far from saturated.
Lingyu, who works in her family business in Shenzhen, is exactly the type of Chinese customer that imitation meat companies want to attract beyond the young, trendy, eco-conscious urbanites. Her yuan means potentially more to meat replacement companies because it advances their business and climate agendas both. Eating less meat is one of the simplest ways to reduce an individual’s carbon footprint and help fight climate change.
McDonald’s hopes that its pea- and soy-based, zero-cholesterol, luncheon meat substitutes will carve out a piece of China’s massive dining market. Longtime rival KFC, and local competitor Dicos introduced their own plant-based products last year. Partnering with fast food chains is a smart move for companies that want to promote alternative protein to the masses, because these products are often pricey and are usually aimed at wealthy urbanites.
2020 could well have been the dawn of alternative protein in China. More than 10 startups raised capital to make plant-based protein for a country with increasing meat demand. Of these, Starfield, Hey Maet, Vesta and Haofood have been around for about a year; ZhenMeat was founded three years ago; and the aforementioned Green Monday is a nine-year-old Hong Kong firm pushing into mainland China. The competition intensified further last year when American incumbents Beyond Meat and Eat Just entered China.
Although some investors worry the sudden boom of meat-substitute startups could turn into a bubble, others believe the market is far from saturated.
“Think about how much meat China consumes a year,” said an investor in a Chinese soy protein startup who requested anonymity. “Even if alternative protein replaces 0.01% of the consumption, it could be a market worth tens of billions of dollars.”
In many ways, China is the ideal testbed for alternative protein. The country has a long history of imitation meat rooted in Buddhist vegetarianism and an expanding middle class that is increasingly health-conscious and willing to experiment. The country also has a grip on the global supply chain for plant-based protein, which could give domestic startups an edge over foreign rivals.
“I believe, in five years, China will see a raft of domestic plant-based protein companies that could be on par with industry leaders from Europe and North America,” said Xie Zihan, who founded Vesta to develop soy-based meat suitable for Chinese cuisine.
Hey Maet’s imitation meat dumplings. Image Credits: Hey Maet
Lily Chen, a manager at the Chinese arm of alternative protein investor Lever VC, outlines three categories of meat analog companies in China: Western giants such as Beyond Meat and Eat Just; local players; and conglomerates such as Unilever and Nestlé that are developing vegan meat product lines as a defense strategy. Lever VC invested in Beyond Meat, Impossible Foods and Memphis Meats.
“They all have their product differentiation, but the industry is still very early stage,” said Chen.
Powered by WPeMatico
Now’s the time for sustainable investments to shine. There are billions of dollars in funding in both public and private markets dedicated to new sustainable investing and demand for consumers for a more conscious capitalism has never been stronger.
As founders and investors reawaken to a sustainable morning in America a few areas are going to demand hardware, software and business model innovations.
Some of these sectors have been on the investment radar for the past year or two and others are just beginning to capture investor attention, but they all have something in common: the investor appetite for new businesses addressing the food supply chain; energy management and construction for homes and offices; carbon sequestration and monitoring and management of offsets; and new biomaterials and processes for packaging and industrial chemicals replacements have never been stronger.
If we’re going to feed the world, let’s start with the food chain.
COVID-19, the disease caused by the SARS-CoV-2 virus, has exposed significant holes in the food supply. Companies like AppHarvest, which agreed to go public through a SPAC earlier this year are only one of several companies remaking agriculture through the application of technology. There’s also Plenty, Bowery Farms, Unfold, BrightFarms and Revol Greens, working to upend the agricultural supply chain. If those companies are looking at new ways of growing crops, companies like Apeel Sciences and Hazel Technologies are trying to find ways to preserve food from spoilage. Treasure8 is looking at ways to use food waste for new food and ingredients and they’re not alone.
Then there’s the protein replacement companies that we’ve written about previously. Impossible Foods, Beyond Meat, Memphis Meats, Mosa Meat, Nuggs, Future Meat Technologies, Shiok Meats (a seafood company) are devising methods to create meaty proteins less dependent on animal husbandry. Perfect Day and its competitors are doing the same for the dairy industry.
There’s also tremendous need for new protein sources to feed the animals that people around the world still like to eat. For this there’re companies like Ynsect, which is providing insect proteins for industrial fish farms, or Grubly Farms, which is providing feed to the families raising their own chickens.
For these opportunities that are raising hundreds of millions in financing there are others that require the kind of high margin software solutions that are yet to be developed. These are visual technologies for tracking, monitoring and managing food production; sensors for improving the storage and supply chain, software for managing production and tracking produce and products from the farm to the table. Venture investors are beginning to invest in these companies as well.
Powered by WPeMatico
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies.
Perhaps the most public (and tastiest) example of the promise biomanufacturing holds is Impossible Foods . The meat replacement company whose ground plants (and bioengineered additives) taste like ground beef just raised another $200 million earlier this month, giving the privately held company a $4 billion valuation.
But Impossible is only the most public face for what’s a growing trend in bioengineering — commercialization. Platform companies like Ginkgo Bioworks and Zymergen that have large libraries of metagenomic data that can be applied to products like industrial chemicals, coatings and films, pesticides and new ways to deliver nutrients to consumers.
In fact, by 2021 consumer products made with Zymergen’s bioengineered thin films should be appearing at the Consumer Electronics Show (if there is a Consumer Electronics Show). It’s one of several announcements this year from the billion dollar-valued startup.
In August, Zymergen announced that it was working with herbicide and pesticide manufacturer FMC in a partnership that will see the seven-year-old startup be an engine for product development at the nearly 130-year-old chemical company.
Powered by WPeMatico
In what could be a starting gun for the commercialization of the cell-based meat business, upstart cultivated meat company Higher Steaks said it has managed to produce samples of its first products — bacon strips and pork belly made in a lab from cellular material.
With the revelation, Higher Steaks, a bootstrapped Cambridge, U.K.-based company, leapfrogs into a competitive position with a number of far larger companies that have raised far more capital.
“There’s still a lot of work until it’s commercial,” said Higher Steaks chief executive Benjamina Bollag, “but the revelation of a pork belly product that’s made from 50% cultivated cells and a bacon product which contains 70% meat grown from a cell material in a laboratory is something of a milestone for the industry.”
The remaining ingredients in Higher Steaks bacon and pork belly are a mixture of plant base, proteins, fats and starches to bind the cellular material together. To achieve this first step on its road to commercialization, Higher Steaks tapped the expertise of an undisclosed chef to formulate the meat into an approximation of the pork belly and bacon.
Higher Steaks head of research and development, Ruth Helen Faram (left) and chief executive Benjamina Bollag (right) Image Credits: Higher Steaks (opens in a new window)
At this stage, the pilot was more to show what Higher Steaks can do rather than what the company will do, said Bollag.
“In the future it will be scaffolding,” said Bollag. “It’s more showing what our meat can do and what we’re working on. In the future it will be with scaffolding.”
A number of companies, including Tantti Laboratories, Matrix Meats and Prellis Biologics, make the kind of biomaterial nano-scale scaffolding that could be used as a frame on which to grow structures equivalent to the fibrous textures of muscle.
The commercial viability of products from companies like Higher Steaks, Memphis Meats, Aleph Farms, Meatable, Integriculture, Mosa Meat and Supermeat depends on more than just companies like Tantti and Matrix, but also on the ability of Thermo Fisher, Future Fields and Merck to bring down the cost of the cell cultures that are required to grow the animal cells.
In all, some 30 cell-based meat startups have launched globally since 2014, and they’re all looking for a slice of the $1.4 trillion meat market.
Meanwhile, demand for pork continues to rise even as supplies have been decimated by an outbreak of African Swine Fever that could have killed as much as 40% of China’s population of pigs in 2019.
“Our mission is to provide meat that is healthy and sustainable without the consumer making any sacrifices on taste,” said Bollag in a statement. “The production of the first ever cultivated bacon and pork belly is proof that new techniques can help meet overwhelming demand for pork products globally.”
Given the highly capitalized competitors that Higher Steaks faces off against, the company is looking for industry partners to help commercialize its technology.
To improve its competitive position, Higher Steaks recently hired Dr. James Clark, the former chief technology officer of PredictImmune.
“I was always quite intrigued by cultured meat production, a mix of both science and food production. In 2013 I watched the first cultured meat burger from Mark Post costing £250,000, cooked on the BBC,” said Clark. “I was approached about joining Higher Steaks earlier this year and was attracted to joining primarily by the science along with the ambition and energy of the Higher Steaks founder Benjamina Bollag . I believe Higher Steaks is a company with a technology to be disruptive in the cultured meat area and at my career stage I was looking for a challenge.”
Brought in to scale the cultivated meat process at Higher Steaks, Clark has led the development of biotech and pharma products at early-stage and publicly traded companies.
“The addition of Dr. James Clark to the team gives Higher Steaks a significant advantage,” said Dr. Ruth Helen Faram, head of R&D. “Cultivated pork belly and bacon have never been demonstrated before and Higher Steaks is the first to develop a prototype containing over 70% cultivated pork muscle, without the use of bovine serum.”
Consumers shouldn’t expect to see Higher Steaks’ pork belly on store shelves or in restaurants anytime soon, Bollag cautioned. “We’re still in the thousands of pounds per kilogram.”
The company does expect to have a larger tasting event later this year.
Powered by WPeMatico
Memphis Meats, a developer of technologies to manufacture meat, seafood and poultry from animal cells, has raised $161 million in financing from investors, including Softbank Group, Norwest and Temasek, the investment fund backed by the government of Singapore.
The investment brings the company’s total financing to $180 million. Previous investors include individual and institutional investors like Richard Branson, Bill Gates, Threshold Ventures, Cargill, Tyson Foods, Finistere, Future Ventures, Kimbal Musk, Fifty Years and CPT Capital.
Other companies, including Future Meat Technologies, Aleph Farms, Higher Steaks, Mosa Meat and Meatable, are pursuing meat grown from cell cultures as a replacement for animal husbandry, whose environmental impact is a large contributor to deforestation and climate change around the world.
Innovations in computational biology, bio-engineering and materials science are creating new opportunities for companies to develop and commercialize technologies that could replace traditional farming with new ways to produce foods that have a much lower carbon footprint and bring about an age of superabundance, according to investors.
The race is on to see who will be the first to market with a product.
“For the entire industry, an investment of this size strengthens confidence that this technology is here today rather than some far-off future endeavor. Once there is a “proof of concept” for cultivated meat — a commercially available product at a reasonable price point — this should accelerate interest and investment in the industry,” said Bruce Friedrich, the executive director of the Good Food Institute, in an email. “This is still an industry that has sprung up almost overnight and it’s important to keep a sense of perspective here. While the idea of cultivated meat has been percolating for close to a century, the very first prototype was only produced six years ago.”
Powered by WPeMatico
Meatable, the Dutch startup developing cruelty-free technologies for manufacturing cultured meat, is pivoting to pork production as a swine flu epidemic ravages one quarter of the world’s pork supply — and has raised $10 million in financing to support its new direction.
When the company unveiled its technology last year, it was one of several companies working on the production of meat derived from animal cells — a method of meat production that theoretically has a far smaller carbon emissions footprint and is better for the environment than traditional animal farming.
At the time, it was one of several companies — including Memphis Meats, Future Meat Technologies, Aleph Farms, HigherSteaks and many, many pursuing technologies — to bring cultured beef to market. Now, as pork prices rise globally, Meatable becomes one of the first companies to publicly shift gears and turn its attention to the other white meat.

That’s not the only way the company is setting itself apart from its peers in the market. Meatable is also an early claimant to a commercially viable, patented process for manufacturing meat cells without the need to kill an animal as a prerequisite for cell differentiation and growth.
Other companies have relied on fetal bovine serum or Chinese hamster ovaries to stimulate cell division and production, but Meatable says it has developed a process where it can sample tissue from an animal, revert that tissue to a pluripotent stem cell, then culture that cell sample into muscle and fat to produce the pork products that palates around the world crave.
“We know which DNA sequence is responsible for moving an early-stage cell to a muscle cell,” says Meatable chief executive Krijn De Nood.
To pursue its new path, the company has raised $7 million from a slew of angel and institutional investors and a $3 million grant from the European Commission . Angel investors include Taavet Hinrikus, the chief executive and co-founder of TransferWise, and Albert Wenger, a managing partner at the New York-based venture firm Union Square Ventures.
Meatable’s De Nood says that the new cash will be used to accelerate the development of its prototype. The small-scale bioreactor the company had initially targeted for development in 2021 will now be ready by 2020 and the company is hoping to have an industry-scale plant online manufacturing thousands of kilograms of meat by 2025, according to De Nood.
Industrial farming is responsible for between 14% and 18% of the greenhouse gas emissions linked to global climate change and Meatable argues that cultured (lab-grown) meat has the potential to use 96% less water and 99% less land than industrial farming. Powering facilities using renewable energy could further reduce emissions associated with meat production, according to Meatable.
Powered by WPeMatico
As the technologies that were once considered science fiction become the purview of science, the venture capital firms that were once investing at the industry’s fringes are now finding themselves at the heart of the technology industry.
Investing in the commercialization of technologies like genetic engineering, quantum computing, digital avatars, augmented reality, new human-computer interfaces, machine learning, autonomous vehicles, robots, and space travel that were once considered “frontier” investments are now front-and-center priorities for many venture capital firms and the limited partners that back them.
Earlier this month, Lux Capital raised $1.1 billion across two funds that invest in just these kinds of companies. “[Limited partners] are now more interested in frontier tech than ever before,” said Bilal Zuberi, a partner with the firm.
Lux Capital just closed on a whopping $1 billion in capital, doubling the amount of money it manages
He sees a few factors encouraging limited partners (the investors who provide financing for venture capital funds) to invest in the firms that are financing companies developing technologies that were once considered outside of the mainstream.
Powered by WPeMatico
In a foodie’s ideal world, we’d all eat healthy, minimally processed cuisine sourced from artisanal farmers, bakers and chefs.
In the real world, however, most of us derive the lion’s share of calories from edibles supplied by a handful of giant food conglomerates. As such, the ingredients and processing techniques they favor have an outsized impact on our daily diets.
With this in mind, Crunchbase News decided to take a look at corporate food VCs and the startups they are backing to see what their dealmaking might say about our snacking future. We put together a list of venture funds operated by some of the larger food and beverage producers, covering literally everything from soup to nuts (plus lunch meat and soda, too!).
Like their corporate backers, startups funded by “Big Food” are a diverse bunch. Recent funding recipients are pursuing endeavors ranging from alternative protein to biospectral imaging to fermented fungus. But if one were to pinpoint an overarching trend, it might be a shift away from cost savings to consumer-friendliness.
“You think of food-tech and ag-tech 1.0, these were technologies that were primarily beneficial to the producers,” said Rob LeClerc, founding partner at AgFunder, an agrifood investor network. “This new generation of companies are really more focused on what does the consumer want.”
And what does the consumer want? This particular consumer would currently like a zero calorie hot fudge sundae. More broadly, however, the general trends LeClerc sees call for food that is healthier, tastier, nutrient-dense, satiating, ethically sourced and less environmentally impactful.
Below, we look at some of the trends in more detail, including funded companies, active investors and the up-and-coming edibles.
Mass-market foods may get better but also weirder. This is particularly true for one of the more consistently hot areas of food-tech investment: alternative protein.
Demand for protein-rich foods, combined with ethical concerns about consuming animal products, has, for a number of years, led investors to startups offering meaty tasting tidbits sourced from the plant world.
But lately, corporate food giants have been looking farther beyond soy and peas. Lab-grown meat, once an oddball endeavor good for headlines about $1,000 meatballs, has been attracting serious cash. Since last year, at least two companies in the space have closed rounds backed by Tyson Ventures, the VC arm of the largest U.S. meat producer. They include pricey meatball maker Memphis Meats (actually based in California), which raised $20 million, and Israel-based Future Meat Technologies, a biotech startup working on animal-free meat, which secured $2 million.
Much of the early enthusiasm for new products stems from disillusionment with the existing ingredients we overeat.
If you cringe at the notion of lab-grown cell meat, then there’s always the option of getting your protein through microbes in volcanic springs. That’s the general aim of Sustainable Bioproducts, a startup that raised $33 million in Series A funding from backers including ADM and Danone Manifesto Ventures. The Chicago company’s technology for making edible protein emerged out of research into extremophile organisms in Yellowstone National Park’s volcanic springs.
Meanwhile, if you hanker for real dairy milk but don’t want to trouble cows, another startup, Perfect Day, is working on a solution. Per the company website: “Instead of having cows do all the work, we use microflora and age-old fermentation techniques to make the very same dairy protein that cows make.” Toward that end, the Berkeley company closed a $35 million Series B in February, with backing from ADM.
Perfect Day isn’t the only fermentation play raising major funding.
Corporate food-tech investors have long been interested in the processing technologies that turn an obscure microbe or under-appreciated crop into a high-demand ingredient. And lately, LeClerc said, they’ve been particularly keen on startups finding new ways to apply the age-old technology known as fermentation.
Most of us know fermentation as the process that turns a yucky mix of grain, yeast and water into the popular beverage known as beer. More broadly, however, fermentation is a metabolic process that produces chemical changes in organic substrates through the action of enzymes. That is, take a substance, add something it reacts with and voilà, you have a new substance.
Several of the most heavily funded, buzz-generating companies in the food space are applying fermentation, LeClerc said. Besides Perfect Day, examples he points to include the unicorn Ginkgo Bioworks, Geltor (another alt-protein startup) and mushroom-focused MycoTechnology.
Colorado-based MycoTechnology has been a particularly attractive investor target of late. The company has raised $83 million from a mix of corporate and traditional VCs, including a $30 million Series C in January that included Tyson and Kellogg’s venture arm, Eighteen94 Capital . Founded six years ago, the company is pursuing a range of applications for its fermented fungi, including flavor enhancers, protein supplements and preservatives.
Besides adding strange new ingredients to our grocery shelves, corporate food-tech investors are also putting money into technologies and platforms aimed at boosting the security and efficiency of existing supply chains.
Just like new foods, much of the food safety tech sounds odd, too. Silicon Valley-based ImpactVision, a seed-funded startup backed by Campbell Soup VC arm Acre Venture Partners, wants to employ hyper-spectral imaging to perceive information about contamination, food quality and ripeness.
Boston-based Spoiler Alert, another Acre portfolio company, develops software and analytics for food companies to manage unsold inventory. And Pensa Systems, which uses AI-powered autonomous drones to track in-store inventory, raised a Series A round this year with backing from the venture arm of Anheuser-Busch InBev.
We highlighted a few trends in corporate food-tech investment, but there are others that merit attention, as well. Probiotics plays, including the maker of the GoodBelly drink line, are generating investor interest. New ingredients other than proteins are also attracting capital, such as UCAN, a startup developing energy snacks based on a novel, slow-digesting carbohydrate. And the list goes on.
Much of the early enthusiasm for new products stems from disillusionment with the existing ingredients we overeat. But LeClerc noted that new products aren’t always better in the long run — they just might seem so at first.
“The question in the back of our head is: Are we ever creating margarine 2.0,” he said. “Just because it’s a plant product doesn’t mean it’s actually better for you.”
Powered by WPeMatico
Here is what your daily menu might look like if recently funded startups have their way.
You’ll start the day with a nice, lightly caffeinated cup of cheese tea. Chase away your hangover with a cold bottle of liver-boosting supplement. Then slice up a few strawberries, fresh-picked from the corner shipping container.
Lunch is full of options. Perhaps a tuna sandwich made with a plant-based, tuna-free fish. Or, if you’re feeling more carnivorous, grab a grilled chicken breast fresh from the lab that cultured its cells, while crunching on a side of mushroom chips. And for extra protein, how about a brownie?
Dinner might be a pizza so good you send your compliments to the chef — only to discover the chef is a robot. For dessert, have some gummy bears. They’re high in fiber with almost no sugar.
Sound terrifying? Tasty? Intriguing? If you checked tasty and intriguing, then here is some good news: The concoctions highlighted above are all products available (or under development) at food and beverage startups that have raised venture and seed funding this past year.
These aren’t small servings of capital, either. A Crunchbase News analysis of venture funding for the food and beverage category found that startups in the space gobbled up more than $3 billion globally in disclosed investment over the past 12 months. That includes a broad mix of supersize deals, tiny seed rounds and everything in-between.
Spending several hours looking at all these funding rounds leaves one with a distinct sense that eating habits are undergoing a great deal of flux. And while we can’t predict what the menu of the future will really hold, we can highlight some of the trends. For this initial installment in our two-part series, we’ll start with foods. Next week, we’ll zero in on beverages.
For protein lovers disenchanted with commercial livestock farming, the future looks good. At least eight startups developing plant-based and alternative proteins closed rounds in the past year, focused on everything from lab meat to fishless fish to fast-food nuggets.
New investments add momentum to what was already a pretty hot space. To date, more than $600 million in known funding has gone to what we’ve dubbed the “alt-meat” sector, according to Crunchbase data. Actual investment levels may be quite a bit higher since strategic investors don’t always reveal round size.
In recent months, we’ve seen particularly strong interest in the lab-grown meat space. At least three startups in this area — Memphis Meats, SuperMeat and Wild Type — raised multi-million dollar rounds this year. That could be a signal that investors have grown comfortable with the concept, and now it’s more a matter of who will be early to market with a tasty and affordable finished product.
Makers of meatless versions of common meat dishes are also attracting capital. Two of the top funding recipients in our data set include Seattle Food Tech, which is working to cost-effectively mass-produce meatless chicken nuggets, and Good Catch, which wants to hook consumers on fishless seafoods. While we haven’t sampled their wares, it does seem like they have chosen some suitable dishes to riff on. After all, in terms of taste, both chicken nuggets and tuna salad are somewhat removed from their original animal protein sources, making it seemingly easier to sneak in a veggie substitute.
Another trend we saw catching on with investors is robot chefs. Modern cooking is already a gadget-driven process, so it’s not surprising investors see this as an area ripe for broad adoption.
Pizza, the perennial takeout favorite, seems to be a popular area for future takeover by robots, with at least two companies securing rounds in recent months. Silicon Valley-based Zume, which raised $48 million last year, uses robots for tasks like spreading sauce and moving pies in and out of the oven. France’s EKIM, meanwhile, recently opened what it describes as a fully autonomous restaurant staffed by pizza robots cooking as customers watch.
Salad, pizza’s healthier companion side dish, is also getting roboticized. Just this week, Chowbotics, a developer of robots for food service whose lineup includes Sally the salad robot, announced an $11 million Series A round.
Those aren’t the only players. We’ve put together a more complete list of recently launched or funded robot food startups here.
Sugar substitutes aren’t exactly a new area of innovation. Diet Rite, often credited as the original diet soda, hit the market in 1958. Since then, we’ve had 60 years of mass-marketing for low-calorie sweeteners, from aspartame to stevia.
It’s not over. In recent quarters, we’ve seen a raft of funding rounds for startups developing new ways to reduce or eliminate sugar in many of the foods we’ve come to love. On the dessert and candy front, Siren Snacks and SmartSweets are looking to turn favorite indulgences like brownies and gummy bears into healthy snack options.
The quest for good-for-you sugar also continues. The latest funding recipient in this space appears to be Bonumuse, which is working to commercialize two rare sugars, Tagatose and Allulose, as lower-calorie and potentially healthier substitutes for table sugar. We’ve compiled a list of more sugar-reduction-related startups here.
It’s tough to tell which early-stage food startups will take off and which will wind up in the scrap bin. But looking in aggregate at what they’re cooking up, it looks like the meal of the future will be high in protein, low in sugar and prepared by a robot.
Powered by WPeMatico
The venture investment arm of massive meat manufacturer Tyson Foods is continuing its push into potential alternative methods of poultry production with a new investment in the Israeli startup Future Meat Technologies.
The backer of companies like the plant-based protein-maker Beyond Meat, and cultured-meat company Memphis Meats, Tyson Ventures’ latest investment is also tackling technology development to create mass-produced meat in a lab — instead of on the farm.
Future Meat Technologies is working to commercialize a manufacturing technology for fat and muscle cells that was first developed in the laboratories of the Hebrew University of Jerusalem.
“It is difficult to imagine cultured meat becoming a reality with a current production price of about $10,000 per kilogram,” said Yaakov Nahmias, the company’s founder and chief scientist, in a statement. “We redesigned the manufacturing process until we brought it down to $800 per kilogram today, with a clear roadmap to $5-10 per kg by 2020.”
The deal marks Tyson’s first investment in an Israeli startup and gives the company another potential horse in the race to develop substitutes for the factory slaughterhouses that provide most of America’s meat.
“This is definitely in the Memphis Meats… in the lab-based meat world,” says Justin Whitmore, executive vice president of corporate strategy and chief sustainability officer of Tyson Foods.
Whitmore takes pains to emphasize that Tyson is continuing to invest in its traditional business lines, but acknowledges that the company believes “in exploring additional opportunities for growth that give consumers more choices,” according to a statement.
While startups like Impossible Foods are focused on developing plant-based alternatives to the proteins that give meat its flavor, Future Meat Technologies and Memphis Meats are trying to use animal cells themselves to grow meat, rather than basically harvesting it from dead animals.
Chef Uri Navon mixing ingredients with FMT’s cultured meat
According to Nahmias, animal fat produces the flavors and aromas that stimulate taste buds, and he says that his company can produce the fat without harvesting animals and without genetic modification.
For Whitmore, what separates Future Meat Technologies and Memphis Meats is the scale of the bioreactors that the companies are using to make their meat. Both companies — indeed all companies on the hunt for a meat replacement — are looking for a way around relying on fetal bovine serum, which is now a crucial component for any lab-cultured meats.
“I want my children to eat meat that is delicious, sustainable and safe,” said Nahmias, in a statement, “this is our commitment to future generations.”
The breadth of backgrounds among the investors that have come together to finance the $2.2 million seed round for Future Meat Technologies speak to the market opportunity that exists for getting a meat manufacturing replacement right.
“Global demand for protein and meat is growing at a rapid pace, with an estimated worldwide market of more than a trillion dollars, including explosive growth in China. We believe that making a healthy, non-GMO product that can meet this demand is an essential part of our mission,” said Rom Kshuk, the chief executive of Future Meat Technologies, in a statement.
One of the company’s first pilot products is lab-grown chicken meat that chefs have already used in some recipes.
FMT’s first cultured chicken kebab on grilled eggplant with tahini sauce
In addition to Tyson Ventures, investors in the Future Meat Technologies seed round included the Neto Group, an Israeli food conglomerate; Seed2Growth Ventures, a Chicago-based fund backed by Walmart wealth; BitsXBites, a Chinese food technology fund; and Agrinnovation, an Israeli investment fund founded by Yissum, the Technology Transfer Company of The Hebrew University,
“Hebrew University, home to Israel’s only Faculty of Agriculture, specializes in incubating applied research in such fields as animal-free meat sources. Future Meat Technologies’ innovations are revolutionizing the sector and leading the way in creating sustainable alternative protein sources,” said Dr. Yaron Daniely, president and CEO of Yissum.
Powered by WPeMatico